MedPath

Follow-Up Extension to the Family Study of Binge Eating Disorder

Completed
Conditions
Binge Eating Disorder
Interventions
Other: No intervention.
Registration Number
NCT00777634
Lead Sponsor
Mclean Hospital
Brief Summary

This study involves a 2.5 and 5 year follow-up interview for individuals who participated in the initial family study of binge eating disorder. The study includes individuals with and without eating disorder as well as their first degree relatives. As part of the study, participants will be interviewed about their current psychiatric and medical symptoms, their blood pressure will be measured, and laboratory specimens will be obtained.

Detailed Description

Previously we completed a family interview study of 150 individuals with binge eating disorder, 150 matched controls, and approximately 888 of their first degree relatives. In follow-up to this, we are interviewing these individuals again at 2.5 and 5 years after their initial interview. During the course of the interview, individuals are asked about their psychiatric and medical history and blood pressure and laboratory specimens are obtained to measure, among other things, fasting lipids and glucose.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
268
Inclusion Criteria
  • Individuals with or without binge eating disorder and their family members who participated in the initial family study of binge eating disorder and agree to be followed up at 2.5 and 5 years.
Exclusion Criteria
  • Unwilling or unable to participate in the follow-up study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Without BEDNo intervention.Individuals who do not meet criteria for binge eating disorder.
Binge eating disorder (BED)No intervention.Individuals who meet criteria for binge eating disorder.
Primary Outcome Measures
NameTimeMethod
Incidence of Diagnosis of Any Metabolic Syndrome ComponentBaseline to 5 years

The number of participants to acquire a new diagnosis of one component of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.

Incidence of Diagnosis of DyslipidemiaBaseline to 5 years

The number of participants to acquire a new diagnosis of high cholesterol (dyslipidemia) over the course of the baseline to five-year followup.

Incidence of Diagnosis of HypertensionBaseline to 5 years

The number of participants to acquire a new diagnosis of high blood pressure(hypertension) over the course of the baseline to five-year followup.

Incidence of Diagnosis of Type 2 DiabetesBaseline to 5 years

The number of participants to acquire a new diagnosis of Type 2 Diabetes over the course of the baseline to five-year followup.

Incidence of Diagnosis of Three or More Metabolic Syndrome ComponentsBaseline to 5 years

The number of participants to acquire a new diagnosis of three or more components of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.

Incidence of Diagnosis of Two or More Metabolic Syndrome ComponentsBaseline to 5 years

The number of participants to acquire a new diagnosis of two or more components of metabolic syndrome. Metabolic syndrome can include abdominal obesity, high blood pressure, high cholesterol, etc.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath